将多西他赛、阿霉素和环磷酰胺作为新辅助治疗用药，可能会降低乳腺癌患者发生淋巴水肿的风险。 - Suppr | 超能文献

Administrating docetaxel, doxorubicin, and cyclophosphamide as a neoadjuvant treatment may decrease lymphedema risk in breast cancer patients.

作者信息

Altundag Kadri

机构信息

MKA Breast Cancer Clinic, Tepe Prime, 06800, Ankara, Cankaya, Turkey.

出版信息

Support Care Cancer. 2018 Jun;26(6):1687. doi: 10.1007/s00520-018-4113-5. Epub 2018 Feb 21.

DOI:10.1007/s00520-018-4113-5

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Administrating docetaxel, doxorubicin, and cyclophosphamide as a neoadjuvant treatment may decrease lymphedema risk in breast cancer patients.将多西他赛、阿霉素和环磷酰胺作为新辅助治疗用药，可能会降低乳腺癌患者发生淋巴水肿的风险。

Support Care Cancer. 2018 Jun;26(6):1687. doi: 10.1007/s00520-018-4113-5. Epub 2018 Feb 21.

2

A Dose-Escalating Pilot Study (NCT03017404) of Pegylated Liposomal Doxorubicin and Cyclophosphamide, Followed by Docetaxel Administration as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer.多柔比星脂质体与环磷酰胺的剂量递增试验（NCT03017404），随后在局部晚期乳腺癌患者中应用多西他赛作为新辅助化疗方案。

Oncol Res Treat. 2019;42(5):269-274. doi: 10.1159/000498993. Epub 2019 Apr 3.

3

Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancer.乳腺癌患者在接受多西紫杉醇、多柔比星和环磷酰胺（TAC）治疗期间和治疗后淋巴水肿的体积和发生率变化。

Support Care Cancer. 2018 May;26(5):1383-1392. doi: 10.1007/s00520-017-3907-1. Epub 2017 Nov 10.

4

Doxorubicin/pemetrexed followed by docetaxel versus doxorubicin/ cyclophosphamide followed by docetaxel as neoadjuvant treatment for early-stage breast cancer: a randomized phase II trial.多柔比星/培美曲塞序贯多西他赛与多柔比星/环磷酰胺序贯多西他赛作为早期乳腺癌新辅助治疗的比较：一项随机II期试验

Clin Breast Cancer. 2007 Apr;7(7):555-8. doi: 10.3816/CBC.2007.n.011.

5

Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer.多西他赛/长春瑞滨新辅助治疗后行手术及多柔比星/环磷酰胺辅助治疗II/III期乳腺癌女性的II期研究

Clin Breast Cancer. 2006 Feb;6(6):511-7. doi: 10.3816/CBC.2006.n.004.

6

A phase II feasibility trial of dose-dense docetaxel followed by doxorubicin/cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk node-negative breast cancer.一项针对淋巴结阳性或高危淋巴结阴性乳腺癌女性患者的II期可行性试验，采用剂量密集多西他赛序贯阿霉素/环磷酰胺作为辅助或新辅助治疗。

Clin Breast Cancer. 2008 Jun;8(3):242-8. doi: 10.3816/CBC.2008.n.027.

7

Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer.多柔比星/环磷酰胺联合与序贯多西他赛作为乳腺癌新辅助治疗。

Eur J Cancer. 2013 Oct;49(15):3102-10. doi: 10.1016/j.ejca.2013.06.012. Epub 2013 Jul 10.

8

Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer.多西他赛、长春瑞滨和曲妥珠单抗新辅助治疗后手术，继以阿霉素加环磷酰胺辅助治疗人表皮生长因子受体2过表达局部晚期乳腺癌女性的II期研究

J Clin Oncol. 2007 Apr 1;25(10):1232-8. doi: 10.1200/JCO.2005.05.3306. Epub 2007 Feb 12.

9

Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study.多柔比星联合多西他赛与多柔比星联合环磷酰胺作为乳腺癌女性主要药物治疗的Ⅲ期随机试验：一项盎格鲁-凯尔特合作肿瘤学组研究

J Clin Oncol. 2005 May 1;23(13):2988-95. doi: 10.1200/JCO.2005.06.156.

10

Effects of docetaxel, doxorubicin and cyclophosphamide on human breast cancer cell line MCF-7.多西他赛、阿霉素和环磷酰胺对人乳腺癌细胞 MCF-7 的影响。

Anticancer Res. 2012 Jul;32(7):2849-54.

本文引用的文献

1

Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancer.乳腺癌患者在接受多西紫杉醇、多柔比星和环磷酰胺（TAC）治疗期间和治疗后淋巴水肿的体积和发生率变化。

Support Care Cancer. 2018 May;26(5):1383-1392. doi: 10.1007/s00520-017-3907-1. Epub 2017 Nov 10.

2

Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.辅助紫杉类药物与乳腺癌相关上肢淋巴水肿的发生。

Br J Surg. 2015 Aug;102(9):1071-8. doi: 10.1002/bjs.9846. Epub 2015 Jun 3.